Impact of Neck Inspiratory Muscle Activation During Sleep in ICU Patients After a COVID 19 ARDS
COVISLEEP
1 other identifier
interventional
17
1 country
1
Brief Summary
Most patients in intensive care units (ICUs) experience severe sleep disruption. Sleep disruption and sleep alteration may have an influence on the ability to breathe spontaneously. But, the cause of altered sleep remains unknown. Previous studies have shown that decreasing nocturnal respiratory muscle activity through mechanical ventilation might improve sleep quality. Nocturnal respiratory muscle activity may be one of the potential factor which contribute to alter sleep in the ICU. Therefore, the aim of this study is to analyse the presence of NIM activation during the night and it's consequence in an ICU population with the same pathology (COVID 19 ARDS).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 28, 2020
CompletedStudy Start
First participant enrolled
April 28, 2020
CompletedFirst Posted
Study publicly available on registry
May 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 9, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 9, 2020
CompletedJune 7, 2021
June 1, 2021
4 months
April 28, 2020
June 4, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of patients with altered spleep
Comparison between patients with NIM activation during the night and patients without NIM activation during the night, in patients COVID 19 ARDS with altered spleep. A Polysomnography (PSG) will be performed the night before extubation.
At day 10 after inclusion
Secondary Outcomes (5)
Sleep architecture at hospital discharge
At day 28 after inclusion
Sleep monitoring during hospital stay after ICU discharge
At day 18 after ICU discharge
Sleep quality
3 months after hospiotal discharge
Sleep architecture at month-3
3 months after hospital discharge
Cost of ICU hospitalization
From inclusion to ICU discharge, up to 10 days after inclusion
Study Arms (1)
Experimental
EXPERIMENTALA Polysomnography (PSG) will be performed in all patient the night before extubation, the day prior discharge and 3 month after. Recording will consist in EEG, EOG et EMG of the chin. We will record NIM EMG. We will also performed an actimetry during hospitalization in the post ICU ward. A quality of sleep questionnaire (Pittsburgh questionnaire) will be completed by the patients during the visit at 3 month.
Interventions
Eligibility Criteria
You may qualify if:
- Patient above 18 year-old admitted to intensive care unit
- COVID-19 assessed by PCR on nasopharyngeal swab or pulmonary sample
- Oro-tracheal intubation for mechanical ventilation
You may not qualify if:
- Guardianship or curatorship
- Prisoners
- No health insurance
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hopital Pellegrin
Bordeaux, 33000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 28, 2020
First Posted
May 1, 2020
Study Start
April 28, 2020
Primary Completion
September 9, 2020
Study Completion
December 9, 2020
Last Updated
June 7, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will not share